Battiti FO - Search Results

1

Chemical manipulations on the 1,4-dioxane ring of 5-HT_1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells.

Del Bello F, Bonifazi A, Giorgioni G, Quaglia W, Amantini C, Morelli MB, Santoni G, Battiti FO, Vistoli G, Cilia A, Piergentili A. Del Bello F, et al. Among authors: battiti fo. Eur J Med Chem. 2019 Apr 15;168:461-473. doi: 10.1016/j.ejmech.2019.02.056. Epub 2019 Feb 25. Eur J Med Chem. 2019. PMID: 30844609

2

Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D₂/D₃ Receptor Bitopic Ligands.

Shaik AB, Boateng CA, Battiti FO, Bonifazi A, Cao J, Chen L, Chitsazi R, Ravi S, Lee KH, Shi L, Newman AH. Shaik AB, et al. Among authors: battiti fo. J Med Chem. 2021 Oct 28;64(20):15313-15333. doi: 10.1021/acs.jmedchem.1c01353. Epub 2021 Oct 12. J Med Chem. 2021. PMID: 34636551 Free PMC article.

3

The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D₃ Receptor (D₃R) Selective Agonists.

Battiti FO, Cemaj SL, Guerrero AM, Shaik AB, Lam J, Rais R, Slusher BS, Deschamps JR, Imler GH, Newman AH, Bonifazi A. Battiti FO, et al. J Med Chem. 2019 Jul 11;62(13):6287-6314. doi: 10.1021/acs.jmedchem.9b00702. Epub 2019 Jul 1. J Med Chem. 2019. PMID: 31257877 Free PMC article.

4

2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.

Newman AH, Battiti FO, Bonifazi A. Newman AH, et al. Among authors: battiti fo. J Med Chem. 2020 Mar 12;63(5):1779-1797. doi: 10.1021/acs.jmedchem.9b01105. Epub 2019 Sep 24. J Med Chem. 2020. PMID: 31499001 Free PMC article.

5

Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine D₃R Bitopic Agonists.

Battiti FO, Newman AH, Bonifazi A. Battiti FO, et al. ACS Med Chem Lett. 2020 Feb 28;11(10):1956-1964. doi: 10.1021/acsmedchemlett.9b00660. eCollection 2020 Oct 8. ACS Med Chem Lett. 2020. PMID: 33062179 Free PMC article.

6

Novel Dual-Target μ-Opioid Receptor and Dopamine D₃ Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management.

Bonifazi A, Battiti FO, Sanchez J, Zaidi SA, Bow E, Makarova M, Cao J, Shaik AB, Sulima A, Rice KC, Katritch V, Canals M, Lane JR, Newman AH. Bonifazi A, et al. Among authors: battiti fo. J Med Chem. 2021 Jun 10;64(11):7778-7808. doi: 10.1021/acs.jmedchem.1c00611. Epub 2021 May 20. J Med Chem. 2021. PMID: 34011153 Free PMC article.

7

Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D₂ or D₃ Receptor Agonists.

Battiti FO, Zaidi SA, Katritch V, Newman AH, Bonifazi A. Battiti FO, et al. J Med Chem. 2021 Nov 11;64(21):16088-16105. doi: 10.1021/acs.jmedchem.1c01433. Epub 2021 Oct 26. J Med Chem. 2021. PMID: 34699207 Free PMC article.

8

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.

Adhikari P, Xie B, Semeano A, Bonifazi A, Battiti FO, Newman AH, Yano H, Shi L. Adhikari P, et al. Among authors: battiti fo. Biomolecules. 2021 Apr 13;11(4):570. doi: 10.3390/biom11040570. Biomolecules. 2021. PMID: 33924613 Free PMC article.

9

Structure of the dopamine D3 receptor bound to a bitopic agonist reveals a new specificity site in an expanded allosteric pocket.

Arroyo-Urea S, Nazarova AL, Carrión-Antolí Á, Bonifazi A, Battiti FO, Lam JH, Newman AH, Katritch V, García-Nafría J. Arroyo-Urea S, et al. Among authors: battiti fo. Res Sq [Preprint]. 2023 Dec 19:rs.3.rs-3433207. doi: 10.21203/rs.3.rs-3433207/v1. Res Sq. 2023. PMID: 38196573 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page